UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adjuvant chemotherapy for non-small cell lung cancer: Ready for clinical practice?

European journal of cancer (1990), 2006, Vol.42 (1), p.8-16

2006

Volltextzugriff (PDF)

High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)

British journal of cancer, 2004-04, Vol.90 (8), p.1521-1525

2004

Volltextzugriff (PDF)

Multi-target inhibitors in non-small cell lung cancer (NSCLC)

Annals of oncology, 2006-04, Vol.17 (suppl-2), p.ii55-ii57

2006

Volltextzugriff (PDF)

Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer

British journal of cancer, 2005-07, Vol.93 (1), p.29-34

2005

Volltextzugriff (PDF)

palliative care Evaluation of effects of early palliative care on quality of life of advanced cancer patients. A multicenter controlled randomised clinical trial

Annals of oncology, 2016-10, Vol.27, p.vi584-vi584

2016

Volltextzugriff (PDF)

Effects of simultaneous care on quality of life of advanced cancer patients. A multicenter controlled randomised clinical trial

Annals of oncology, 2016-09, Vol.27, p.iv55

2016

Volltextzugriff (PDF)

Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma. A prospective study

Cancer, 1999-04, Vol.85 (7), p.1599-1605

1999

Volltextzugriff (PDF)

Gemcitabine, ifosfamide, cisplatin (GIP) for the treatment of advanced non‐small cell lung cancer: A phase II study of the Italian oncology group for clinical research (goirc)

International journal of cancer, 2000-09, Vol.87 (5), p.724-727

2000

Volltextzugriff (PDF)

1134 POSTER Survival prediction of terminally ill cancer patients by clinical and laboratory parameters: usefullness role of simple prognostic indicators

European journal of cancer supplements, 2007, Vol.5 (4), p.152-152

2007

Volltextzugriff (PDF)

Survey on Models of Integration of Oncology and Palliative Care (PC) in Italian Oncology Units Esmo Designated Centers

Annals of oncology, 2012-09, Vol.23, p.ix466

2012

Volltextzugriff (PDF)

Low-dose aminoglutethimide with and without hydrocortisone replacement as a first-line endocrine treatment in advanced breast cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research

Journal of clinical oncology, 1992-06, Vol.10 (6), p.984-989

1992

Volltextzugriff (PDF)

Importance of Early Combined N-Terminal Pro–Brain Natriuretic Peptide and Cardiac Troponin T Measurements for Long-term Risk Stratification of Patients With Decompensated Heart Failure

The Journal of heart and lung transplantation, 2006-10, Vol.25 (10), p.1230-1240

2006

Volltextzugriff (PDF)

Suspension bridge analysis using lagrangian approach

Computers & structures, 1987, Vol.26 (3), p.499-512

1987

Volltextzugriff (PDF)

Comparison between epidermal growth factor receptor (EGFR) gene in primary non-small cell lung cancer (NSCLC) and in fine needle aspirates from metastatic sites

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.21081-21081

2007

Volltextzugriff (PDF)

Immunoglobulin G fragment C receptor polymorphisms and response to trastuzumab-based treatment in patients with HER-2/neu-positive metastatic breast cancer

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.13090-13090

2006

Volltextzugriff (PDF)

Different expression of BRCA1 status and clinical variables in a sample of Italian women with early onset breast cancer (EOBC)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.9670-9670

2004

Volltextzugriff (PDF)

Different expression of BRCA1 status and clinical variables in a sample of Italian women with early onset breast cancer (EOBC)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.9670-9670

2004

Volltextzugriff (PDF)

P-961 Buccal mucosa cells as “in vivo” model to evaluate gefitinib response in NSCLC patients

Lung cancer (Amsterdam, Netherlands), 2005-07, Vol.49, p.S372-S373

2005

Volltextzugriff (PDF)

Male breast cancer in Parma Province: Descriptive epidemiology, molecular markers and clinical variables

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.9655-9655

2004

Volltextzugriff (PDF)

Male breast cancer in Parma Province: Descriptive epidemiology, molecular markers and clinical variables

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.9655-9655

2004

Volltextzugriff (PDF)

Biological variables in non-small cell lung cancer: comparison between immunocytochemical determination on fine needle aspirates from surgical specimens and immunohistochemical determination on tissue sections

Lung cancer (Amsterdam, Netherlands), 2000-07, Vol.29 (1), p.33-41

2000

Volltextzugriff (PDF)

BRCA1 status, molecular markers, clinical variables in breast cancer patients with high probability of having an inherited genetic mutation

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.9648-9648

2004

Volltextzugriff (PDF)

BRCA1 status, molecular markers, clinical variables in breast cancer patients with high probability of having an inherited genetic mutation

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.9648-9648

2004

Volltextzugriff (PDF)

Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma. A prospective study

Cancer, 1999-09, Vol.86 (5), p.900-902

Nieder, C

1999

Volltextzugriff (PDF)

Adjuvant systemic therapies in women with breast cancer: an audit of clinical practice in Italy

Annals of oncology, 2003-06, Vol.14 (6), p.843-848

2003

Volltextzugriff (PDF)

1 – 25 von 177

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(144)
Mit Volltextzugriff
(152)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(96)
Life Sciences & Biomedicine
(53)
Humans
(42)
Female
(39)
Physical Sciences
(34)
Technology
(29)
Physics
(28)
Biological And Medical Sciences
(26)
Materials Science
(23)
Male
(21)
Physics, Applied
(21)
Animals
(19)
Materials Science, Multidisciplinary
(19)
Middle Aged
(18)
Exact Sciences And Technology
(17)
Medical Sciences
(16)
Physics, Condensed Matter
(15)
Aged
(14)
Oncology
(13)
Fundamental And Applied Biological Sciences. Psychology
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Adjuvant chemotherapy for non-small cell lung cancer: Ready for clinical practice?

High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)

Multi-target inhibitors in non-small cell lung cancer (NSCLC)

Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer

palliative care Evaluation of effects of early palliative care on quality of life of advanced cancer patients. A multicenter controlled randomised clinical trial

Effects of simultaneous care on quality of life of advanced cancer patients. A multicenter controlled randomised clinical trial

Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma. A prospective study

Gemcitabine, ifosfamide, cisplatin (GIP) for the treatment of advanced non‐small cell lung cancer: A phase II study of the Italian oncology group for clinical research (goirc)

1134 POSTER Survival prediction of terminally ill cancer patients by clinical and laboratory parameters: usefullness role of simple prognostic indicators

Survey on Models of Integration of Oncology and Palliative Care (PC) in Italian Oncology Units Esmo Designated Centers

Low-dose aminoglutethimide with and without hydrocortisone replacement as a first-line endocrine treatment in advanced breast cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research

Importance of Early Combined N-Terminal Pro–Brain Natriuretic Peptide and Cardiac Troponin T Measurements for Long-term Risk Stratification of Patients With Decompensated Heart Failure

Suspension bridge analysis using lagrangian approach

Comparison between epidermal growth factor receptor (EGFR) gene in primary non-small cell lung cancer (NSCLC) and in fine needle aspirates from metastatic sites

Immunoglobulin G fragment C receptor polymorphisms and response to trastuzumab-based treatment in patients with HER-2/neu-positive metastatic breast cancer

Different expression of BRCA1 status and clinical variables in a sample of Italian women with early onset breast cancer (EOBC)

Different expression of BRCA1 status and clinical variables in a sample of Italian women with early onset breast cancer (EOBC)

P-961 Buccal mucosa cells as “in vivo” model to evaluate gefitinib response in NSCLC patients

Male breast cancer in Parma Province: Descriptive epidemiology, molecular markers and clinical variables

Male breast cancer in Parma Province: Descriptive epidemiology, molecular markers and clinical variables

Biological variables in non-small cell lung cancer: comparison between immunocytochemical determination on fine needle aspirates from surgical specimens and immunohistochemical determination on tissue sections

BRCA1 status, molecular markers, clinical variables in breast cancer patients with high probability of having an inherited genetic mutation

BRCA1 status, molecular markers, clinical variables in breast cancer patients with high probability of having an inherited genetic mutation

Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma. A prospective study

Adjuvant systemic therapies in women with breast cancer: an audit of clinical practice in Italy

Suchergebnisse filtern